Table 1
Number of eligible cases,Note † distribution by sex and age group, and cancer-specific proportion by sex, Canada excluding Quebec, 1999-to-2008 period

Table 1
Number of eligible cases,† distribution by sex and age group, and cancer-specific proportion by sex, Canada excluding Quebec, 1999-to-2008 period
Table summary
This table displays the results of Number of eligible cases. The information is grouped by Cancer (appearing as row headers), Age group (years), 15 to 99, 15 to 44, 45 to 54, 55 to 64, 65 to 74 and 75 to 99, calculated using Cases, % women, % of men and % of women units of measure (appearing as column headers).
Cancer Age group (years)
15 to 99 15 to 44 45 to 54 55 to 64 65 to 74 75 to 99
Cases % women % of menNote ‡ % of womenNote ‡ Cases % women Cases % women Cases % women Cases % women Cases % women
All cancersNote § 706,590 43.7 100.0 100.0 57,075 53.4 83,825 44.2 141,370 39.8 191,530 39.2 232,785 47.1
Oral cavity and pharynx 24,665 32.4 4.2 2.6 2,415 39.0 4,710 26.3 6,160 26.9 5,780 30.4 5,600 42.8
Esophagus 10,795 26.7 2.0 0.9 300 16.6 1,170 17.8 2,370 18.7 3,185 24.3 3,775 37.5
Stomach 21,190 35.3 3.4 2.4 1,035 48.6 2,245 34.0 3,860 28.1 5,755 30.2 8,290 40.8
Colon 94,155 49.0 12.1 15.0 3,075 51.0 8,105 47.7 17,230 43.1 27,015 43.9 38,730 55.4
Rectum 44,720 38.4 6.9 5.6 1,845 45.5 5,600 39.5 10,170 33.1 12,865 33.2 14,245 45.5
Liver 8,750 24.5 1.7 0.7 410 24.7 1,490 15.3 2,050 19.4 2,520 24.6 2,285 34.7
Pancreas 24,000 50.4 3.0 3.9 680 46.2 2,210 42.3 4,535 41.4 6,730 46.1 9,845 59.6
Larynx 7,190 16.8 1.5 0.4 190 22.2 885 16.6 2,010 15.7 2,345 16.9 1,760 17.7
Lung and bronchus 143,465 45.0 19.8 20.9 2,725 56.1 12,615 51.8 31,130 45.6 48,535 42.6 48,460 44.7
Skin melanoma 36,310 47.0 4.8 5.5 7,445 59.5 7,085 51.2 7,190 41.4 6,960 38.2 7,630 44.1
Bladder (including in situ) 42,235 25.2 7.9 3.5 1,040 34.0 3,170 26.6 7,510 24.5 12,610 21.7 17,910 27.3
Kidney and renal pelvis 28,565 39.0 4.4 3.6 2,190 39.2 4,735 35.2 6,960 34.5 7,425 38.7 7,255 46.0
Brain and other nervous system 15,815 43.3 2.3 2.2 3,500 42.4 2,615 39.2 3,295 40.5 3,265 41.4 3,145 52.8
Thyroid 24,845 77.7 1.4 6.3 10,605 82.5 6,080 78.7 4,200 72.9 2,480 66.6 1,480 72.2
Hodgkin lymphoma 6,210 45.0 0.9 0.9 3,805 46.6 755 35.8 610 42.5 545 42.0 495 53.4
Non-Hodgkin lymphoma 45,400 45.7 6.2 6.7 5,195 41.2 6,420 41.7 9,300 44.1 11,160 44.5 13,330 51.5
Multiple myeloma 13,530 45.3 1.9 2.0 395 40.8 1,335 41.6 2,700 40.9 3,820 43.9 5,285 49.8
Leukemia 29,540 41.4 4.3 4.0 3,265 41.9 3,345 38.2 5,445 37.4 7,270 38.5 10,225 46.6
OtherNote § and unknown 85,210 46.8 11.4 12.9 6,965 47.2 9,255 45.6 14,660 43.3 21,280 42.5 33,050 51.3
Note †

cases diagnosed during 1999-to-2008 period that were potentially eligible for period survival analysis from 2004 to 2008; case counts randomly rounded to base of 5 for confidentiality

Return to note † referrer

Note ‡

sex-specific distribution of cancer cases by cancer type

Return to note ‡ referrer

Note §

excluding genital system cancers and breast cancer

Return to note § referrer

Source: Canadian Cancer Registry database.

More information

ISSN: 1209-1367

Note of appreciation

Canada owes the success of its statistical system to a long-standing partnership between Statistics Canada, the citizens of Canada, its businesses, governments and other institutions. Accurate and timely statistical information could not be produced without their continued co-operation and goodwill.

Standards of service to the public

Statistics Canada is committed to serving its clients in a prompt, reliable and courteous manner. To this end, the Agency has developed standards of service which its employees observe in serving its clients.

Copyright

Published by authority of the Minister responsible for Statistics Canada.

© 2016 Minister of Industry

Use of this publication is governed by the Statistics Canada Open Licence Agreement.

Catalogue no. 82-003-X

Frequency: Monthly

Ottawa

close
Date modified: